Doi, T., Fuse, N., Yoshino, T., Kojima, T., Bando, H., Miyamoto, H., . . . Ohtsu, A. (2016). A Phase I study of intravenous PI3K inhibitor copanlisib in Japanese patients with advanced or refractory solid tumors. Cancer Chemother Pharmacol.
Chicago Stili AlıntıDoi, Toshihiko, Nozomu Fuse, Takayuki Yoshino, Takashi Kojima, Hideaki Bando, Hideaki Miyamoto, Masato Kaneko, Motonobu Osada, ve Atsushi Ohtsu. "A Phase I Study of Intravenous PI3K Inhibitor Copanlisib in Japanese Patients With Advanced or Refractory Solid Tumors." Cancer Chemother Pharmacol 2016.
MLA AlıntıDoi, Toshihiko, et al. "A Phase I Study of Intravenous PI3K Inhibitor Copanlisib in Japanese Patients With Advanced or Refractory Solid Tumors." Cancer Chemother Pharmacol 2016.